Strategies for Hepatitis C Testing and Treatment in Aboriginal Communities That Lead to Elimination

Last updated: April 13, 2022
Sponsor: Kirby Institute
Overall Status: Active - Recruiting

Phase

N/A

Condition

Gastrointestinal Diseases And Disorders

Hepatitis

Liver Disorders

Treatment

N/A

Clinical Study ID

NCT03776760
VHCRP1802
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

A community-based "test and treat" intervention integrating point-of-care HCV RNA testing, non-invasive liver disease assessment and linkage to care will lead to a reduction in HCV prevalence among people attending Aboriginal health services.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • 18 years of age or older;
  • voluntarily signed the informed consent form.

Exclusion

Exclusion Criteria:

  • Pregnant women.

Study Design

Total Participants: 600
Study Start date:
May 28, 2019
Estimated Completion Date:
August 31, 2022

Study Description

SCALE-C is an interventional cohort study recruiting people with or at risk of HCV infection from Aboriginal health services in Australia. Participants will be screened for HCV infection using point-of-care testing (anti-HCV antibody and/or HCV RNA). People with current HCV infection (HCV RNA positive) will be offered treatment with eight or 12 weeks of pan-genotypic DAA therapy, glecaprevir/pibrentasvir or sofosbuvir/velpatasvir, as available on the PBS.

Connect with a study center

  • Jullums Lismore Aboriginal Medical Service

    Lismore, New South Wales 2480
    Australia

    Active - Recruiting

  • Walhallow Aboriginal Corporation

    Quirindi, New South Wales 2343
    Australia

    Active - Recruiting

  • Pangula Mannamurna Aboriginal Corporation

    Mount Gambier, South Australia 5290
    Australia

    Active - Recruiting

  • Port Lincoln Aboriginal Health Service

    Port Lincoln, South Australia 5606
    Australia

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.